Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03862027 · ClinicalTrials.gov registry record · NA
Safety of Optimal PEEP in NSICU Patients
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03862027 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1 participants.
The verdict
NCT03862027, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The investigators aim to demonstrate that use of transpulmonary pressure to guide PEEP management is safe in patients with possible elevations of intracranial pressure.
Interventions
- DEVICE Esophageal Balloon catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2019-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03862027
The ClinicalTrials.gov registry entry for NCT03862027 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Esophageal Balloon catheter is the first listed.
NCT03862027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03862027 about?
NCT03862027 is a clinical study titled "Safety of Optimal PEEP in NSICU Patients". The investigators aim to demonstrate that use of transpulmonary pressure to guide PEEP management is safe in patients with possible elevations of intracranial pressure.
What is the current status of trial NCT03862027?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-03-01. Estimated completion is 2019-03-04.
What interventions are being tested in trial NCT03862027?
The interventions under investigation include: Esophageal Balloon catheter (DEVICE).
Who is sponsoring clinical trial NCT03862027?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.